stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Recursion Pharmaceuticals IncRXRX
$2.5911.02%-0.32

Recursion Pharmaceuticals Inc (RXRX)

Recursion Pharmaceuticals Inc stock is traded at $2.59, with a volume of 27,959,812. It is down -11.02% in the last 24 hours and down -25.40% over the past month. Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
Previous Close:
$2.91
Open:
$2.95
24h Volume:
27,959,812
Relative Volume:
1.43
Market Cap:
$1.61B
Revenue:
$66.41M
Net Income/Loss:
-$559.78M
P/E Ratio:
-
EPS:
-$1.20
Net Cash Flow:
-$328.09M
1W Performance:
-27.18%
1M Performance:
-25.40%
6M Performance:
-11.77%
1Y Performance:
-37.26%
1-Day Range:
$2.50$2.95
1-Week Range:
$2.50$3.72
52-Week Range:
$2.50$5.24

Recursion Pharmaceuticals Inc Stock (RXRX) Company Profile

Name
Recursion Pharmaceuticals Inc
Phone
(385) 269-0203
Address
41S RIO GRANDE STREET, SALT LAKE CITY, USA
Employee
600
X
-
Next Earnings Date
-
Latest SEC Filings
SEC
RXRX's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Recursion Pharmaceuticals Inc Stock (RXRX) Financials Data

Similar to RXRX